60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) has a beta value of 2.76 and has seen 2.92 million shares traded in the last trading session. The company, currently valued at $3.19M, closed the last trade at $2.16 per share which meant it lost -$0.36 on the day or -14.09% during that session. The SXTP stock price is -1566.2% off its 52-week high price of $35.99 and 34.72% above the 52-week low of $1.41. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.37 million shares traded. The 3-month trading volume is 195.53K shares.
The consensus among analysts is that 60 Degrees Pharmaceuticals Inc (SXTP) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -1.24.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
Sporting -14.09% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SXTP stock price touched $2.16 or saw a rise of 19.7%. Year-to-date, 60 Degrees Pharmaceuticals Inc shares have moved -84.11%, while the 5-day performance has seen it change -7.08%. Over the past 30 days, the shares of 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) have changed -9.41%. Short interest in the company has seen 37468.0 shares shorted with days to cover at 0.15.
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
The company’s shares have lost -60.28% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 130.43%.
1 analysts offering their estimates for the company have set an average revenue estimate of 320k for the current quarter. 1 have an estimated revenue figure of 380k for the next ending quarter. Year-ago sales stood 124.97k and 135.29k respectively for this quarter and the next, and analysts expect sales will grow by 156.06% for the current quarter and 130.43% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 12.29% over the past 5 years.
SXTP Dividends
60 Degrees Pharmaceuticals Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
Insiders own 4.97% of the company shares, while shares held by institutions stand at 7.30% with a share float percentage of 7.68%. Investors are also buoyed by the number of investors in a company, with 60 Degrees Pharmaceuticals Inc having a total of 8.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of May 31, 2025 , the former fund manager holds about 0.65% shares in the company for having 9.6 shares of worth $20775.0 while later fund manager owns 2.24 shares of worth $4840.0 as of May 31, 2025 , which makes it owner of about 0.15% of company’s outstanding stock.
